Company: IMRX
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001790340-25-000053
Chunk: 45

Company: Immuneering Corp
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 45
---
 stock options vest in full upon the occurrence of a change in control. The vesting of the stock options is in all cases subject to the applicable non-employee director’s continuous service as a non-employee director through the applicable vesting date, provided that the vesting of any Elective Option issued in respect of the COB or LID Retainer is subject to the non-employee director’s continued service as the chair of the Board of Directors or lead independent director, as applicable.

Director fees under the program are payable in arrears in four equal quarterly installments not later than the fifteenth day following the final day of each calendar quarter, provided that the non-employee director has not elected to receive an Elective Option in lieu thereof. The amount of each payment is prorated for any portion of a quarter that a director is not serving as non-employee member of our Board of Directors.

Dr. Zeskind, our President and Chief Executive Officer, serves on our Board of Directors but does not receive additional compensation for his service as a director. Refer to the discussion of named executive officer compensation elsewhere in this section for information regarding Dr. Zeskind’s 2024 compensation.

#### 2024 Director Compensation Table
| Name                       |     |    Fees 
  earned 
 or paid 
 in cash 
     ($) |     |        Option 
 awards ($)(1) |     | All other        
 compensation ($) |     | Total ($) |
| Ann E. Berman              |     |  89,000 |     |        39,740 |     | —                |     |   128,740 |
| Robert J. Carpenter        |     |  45,000 |     |        39,740 |     | —                |     |    84,740 |
| Peter Feinberg(2)          |     |  51,500 |     |        39,740 |     | —                |     |    91,240 |
| Diana F. Hausman, M.D.     |     |  53,000 |     |        39,740 |     | —                |     |    92,740 |
| Laurie B. Keating(2)       |     |  57,500 |     |        39,740 |     | —                |     |    97,240 |
| Thomas J. Schall, Ph.D.(3) |     |  33,338 |     |